Radboudumc and partners Help Cell4Pharma

21 December 2022

We need to work towards a future where organ on a chip technology is more accurate in mimicking the human body than any animal could ever be.Because over 110 million animals are used in experiments to develop new medicine. Organ by organ we will need to develop better alternatives than the experiments that are done on animals now.

Our spin-off company Cell4Pharma focuses on developing a model that is more accurate in mimicking the human kidney than any other animal experiment on the market.

Grab this opportunity to be part of their mission and become an investor.

Check out their crowdfunding page on Symbid here: http://www.symbid.nl/projects/427

Related news items

Soteria Medical BV announces collaboration with ALLEAD

27 July 2023

Radboudumc spin-off Soteria Medical BV announces collaboration with ALLEAD.

read more

Take Off 2 funding from NWO for Predica Diagnostics

30 June 2023

Predica Diagnostics just secured the Take Off 2 funding to accelerate development of their cervical (pre)cancer prediction test.

read more

Boosting the startup ecosystem in Nijmegen!

22 June 2023

TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.

read more

Meet Healthy Ideas, Healthy Returns

2 June 2023

Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.

read more

Cell4Pharma successfully closed a major funding round

25 May 2023

Radboudumc spin-off Cell4Pharma is pleased to announced it has successfully closed a major funding round, marking a significant milestone in their journey towards developing ciPTEC as the leading platform to study human renal biological interaction during the preclinical stages of drug development

read more

Kick-off collaboration on 3D printed orthoses with Spentys and atum3D

7 February 2023

atum3D and Spentys hosted a workshop on 3D printed orthoses, a break-through development made possible through collaboration with the Department of Surgery - Trauma Unit and the 3D lab of Radboudumc.

read more